by Developer1 | Jun 14, 2021 | Funding
Funding from the National Cancer Institute will help optimize patient engagement in research while studying osteosarcoma and leiomyosarcoma The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Count Me In, a non-profit research initiative that...
by Developer1 | Jun 10, 2021 | Testing
In many adult cancers, at diagnosis, a biopsy of the tumor is done and some of the tumor tissue is sent off for genetic testing. Then, depending on the results of the genetic testing, a particular treatment is chosen by the doctor. For Osteosarcoma there is only one...
by Developer1 | Jun 10, 2021 | Testing
When a child is diagnosed with osteosarcoma very young (typically below the age of 10) or has a strong family history of sarcomas/breast cancer/GBM, or when a patient relapses, genetic testing may be mentioned. There are two distinct types of genetic testing looking...
